Sorrento Therapeutics Gets $2.3M
socalTECH
JUNE 19, 2009
in an equity funding round, according to a regulatory filing by the firm yesterday. Source of the funding was not disclosed. Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom. Tags: sorrento therapeutics biotech venture capital lifescience aviaradx.
Let's personalize your content